舒泰神(300204)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300204 舒泰神

已收盘 09-30 15:00:00

{"stockData":{"symbol":"300204","market":"SZ","secType":"STK","nameCN":"舒泰神","latestPrice":35.01,"timestamp":1759215807000,"preClose":33.65,"halted":0,"volume":18054996,"delay":0,"changeRate":0.0404,"floatShares":454000000,"shares":478000000,"eps":-0.3476,"marketStatus":"已收盘","change":1.36,"latestTime":"09-30 15:00:00","open":33.58,"high":35.17,"low":33.58,"amount":623000000,"amplitude":0.0473,"askPrice":35.02,"askSize":50,"bidPrice":35.01,"bidSize":26,"shortable":0,"etf":0,"ttmEps":-0.3476,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1759973400000},"marketStatusCode":5,"adr":0,"adjPreClose":33.65,"symbolType":"stock","openAndCloseTimeList":[[1759195800000,1759203000000],[1759208400000,1759215600000]],"highLimit":37.02,"lowLimit":30.29,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":477772555,"isCdr":false,"pbRate":15.35,"roa":"--","roe":"--","epsLYR":-0.3,"committee":-0.082717,"marketValue":16727000000,"turnoverRate":0.0398,"status":0,"floatMarketCap":15883000000},"requestUrl":"/m/hq/s/300204","defaultTab":"news","newsList":[{"id":"2574715759","title":"股市必读：舒泰神（300204）9月30日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2574715759","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574715759?lang=zh_cn&edition=full","pubTime":"2025-10-09 02:57","pubTimestamp":1759949830,"startTime":"0","endTime":"0","summary":"截至2025年9月30日收盘，舒泰神报收于35.01元，上涨4.04%，换手率3.98%，成交量18.05万手，成交额6.23亿元。董秘最新回复投资者： 能不能增持回购多搞搞，都跌多少了董秘： 您好！感谢您的关注和建议，谢谢！交易信息汇总资金流向9月30日主力资金净流入875.74万元，占总成交额的1.4%；游资资金净流入5002.66万元，占总成交额的8.02%；散户资金净流出5878.4万元，占总成交额的9.43%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900000849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0046","300204"],"gpt_icon":0},{"id":"2569358667","title":"舒泰神（300204）披露召开2025年第二次临时股东会提示性公告，9月22日股价上涨2.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569358667","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569358667?lang=zh_cn&edition=full","pubTime":"2025-09-22 22:52","pubTimestamp":1758552744,"startTime":"0","endTime":"0","summary":"截至2025年9月22日收盘，舒泰神报收于36.31元，较前一交易日上涨2.28%，最新总市值为173.48亿元。该股当日开盘35.9元，最高36.9元，最低35.64元，成交额达5.66亿元，换手率为3.45%。公司近日发布公告称，将于2025年09月25日召开2025年第二次临时股东会，会议采用现场与网络投票相结合方式。股权登记日为2025年09月17日。登记时间为2025年09月23日，可通过现场、信函或传真方式登记。本次股东会由董事会召集，会议合法合规。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200035116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0028","300204"],"gpt_icon":0},{"id":"2568955734","title":"9月17日舒泰神发布公告，股东减持619.47万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2568955734","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568955734?lang=zh_cn&edition=full","pubTime":"2025-09-17 20:03","pubTimestamp":1758110598,"startTime":"0","endTime":"0","summary":"证券之星消息，9月17日舒泰神发布公告《舒泰神:关于持股5%以上股东减持股份触及1%整数倍暨减持计划实施完毕的公告》，其股东香塘集团有限公司于2025年9月10日至2025年9月16日间合计减持619.47万股，占公司目前总股本的1.2966%，变动期间该股股价下跌0.7%，截止9月16日收盘报38.14元。股东增减持详情见下表：根据舒泰神2025年中报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091700036568.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","BK0028","300204"],"gpt_icon":0},{"id":"2567103155","title":"9月16日舒泰神现9笔折价15%的大宗交易 合计成交1.51亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567103155","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567103155?lang=zh_cn&edition=full","pubTime":"2025-09-16 17:22","pubTimestamp":1758014555,"startTime":"0","endTime":"0","summary":"证券之星消息，9月16日舒泰神发生大宗交易，交易数据如下：近三个月该股共发生11笔大宗交易，合计成交4.78万手，折价成交11笔。该股近期无解禁股上市。截至2025年9月16日收盘，舒泰神(300204)报收于38.14元，下跌1.01%，换手率4.54%，成交量20.6万手，成交额7.89亿元。该股近半年内有股东持股变动，合计净减持336.07万股，股东增减持明细如下表：该股最近90天内共有1家机构给出评级，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091600027392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","BK0046","300204"],"gpt_icon":0},{"id":"2566608696","title":"舒泰神最新公告：香塘集团减持336.07万股公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2566608696","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566608696?lang=zh_cn&edition=full","pubTime":"2025-09-10 18:50","pubTimestamp":1757501445,"startTime":"0","endTime":"0","summary":"舒泰神(300204.SZ)公告称，公司持股5%以上股东香塘集团有限公司于2025年09月08日、2025年09月09日通过证券交易所集中竞价交易方式减持336.07万股舒泰神股份，占公司有表决权总股本的0.70%，目前香塘集团及其一致行动人合计持股比例由7.69%下降至6.99%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091000031653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300204","BK0239","BK0046"],"gpt_icon":0},{"id":"2566611435","title":"“寒王”大消息，近40亿定增获批！3家公司齐发公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2566611435","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566611435?lang=zh_cn&edition=full","pubTime":"2025-09-10 00:32","pubTimestamp":1757435544,"startTime":"0","endTime":"0","summary":"批量定增","market":"hk","thumbnail":"https://img3.gelonghui.com/46be0-5457e136-5622-4afe-8d43-e1d1b9717976.jpg?guru_height=799&guru_width=1280&guru_size=85812","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/46be0-5457e136-5622-4afe-8d43-e1d1b9717976.jpg?guru_height=799&guru_width=1280&guru_size=85812"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/2806191","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["SG9999001069.SGD","SG9999001051.SGD","BK0010","300204","SGXZ90724238.SGD","BK0143","BK0188","BK0231","002281","SGXZ49509284.SGD","SG9999001093.SGD","SG9999002950.SGD","688256","BK0123","BK0148","BK0028","BK0239","BK0167","SG9999003461.SGD","BK0046","BK0198","SG9999006597.SGD","BK0214","BK0122","SGXZ81163826.USD","BK0197","BK0164"],"gpt_icon":1},{"id":"2566607596","title":"舒泰神(300204.SZ)拟定增股票募资不超12.53亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566607596","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566607596?lang=zh_cn&edition=full","pubTime":"2025-09-09 17:03","pubTimestamp":1757408598,"startTime":"0","endTime":"0","summary":"智通财经APP讯，舒泰神(300204.SZ)发布2025 年度向特定对象发行股票预案，本次发行募集资金总额不超过(含)人民币12.53亿元，在扣除相关发行费用后的募集资金净额将全部用于以下项目：8.83亿元用于创新药物研发项目；3.7亿元用于补充流动资金。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1343136.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"舒泰神(300204.SZ)拟定增股票募资不超12.53亿元","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0028","BK0046","300204"],"gpt_icon":0},{"id":"2562383727","title":"舒泰神股价下跌6.53% 公司回应股东人数披露问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2562383727","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562383727?lang=zh_cn&edition=full","pubTime":"2025-08-28 03:25","pubTimestamp":1756322739,"startTime":"0","endTime":"0","summary":"截至2025年8月27日收盘，舒泰神股价报53.00元，较前一交易日下跌3.70元，跌幅6.53%。当日成交量为341939手，成交金额达18.75亿元。舒泰神属于生物医药板块，专注于创新药物研发。公司主要产品包括治疗神经系统疾病和免疫系统疾病的生物制剂。公司近期在互动平台回应投资者提问时表示，已按照信息披露要求在定期报告中披露相应时间点的股东人数。资金流向方面，8月27日舒泰神主力资金净流出3.45亿元，近五日主力资金累计净流出7.41亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/28032552759122.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0028","BK0046","300204"],"gpt_icon":0},{"id":"2562276315","title":"舒泰神（300204）2025年中报简析：净利润同比下降619.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562276315","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562276315?lang=zh_cn&edition=full","pubTime":"2025-08-27 06:26","pubTimestamp":1756247179,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期舒泰神发布2025年中报。根据财报显示，舒泰神净利润同比下降619.7%。截至本报告期末，公司营业总收入1.26亿元，同比下降31.14%，归母净利润-2463.56万元，同比下降619.7%。按单季度数据看，第二季度营业总收入6238.33万元，同比下降28.63%，第二季度归母净利润-2230.05万元，同比下降6538.03%。本次财报公布的各项数据指标表现不尽如人意。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082700008755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204"],"gpt_icon":0},{"id":"2562279468","title":"多只大牛股披露半年报 长城军工、舒泰神亏损 多家行业龙头业绩出炉","url":"https://stock-news.laohu8.com/highlight/detail?id=2562279468","media":"券商中国","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562279468?lang=zh_cn&edition=full","pubTime":"2025-08-26 07:38","pubTimestamp":1756165080,"startTime":"0","endTime":"0","summary":"　　中报业绩披露，进入高峰期！　　8月25日晚间，长城军工、涛涛车业、天孚通信、大元泵业、舒泰神、华通线缆、拓维信息等多只大牛股披露了中报业绩。其中，高德红外上半年净利同比增长超900%。　　长城军工25日晚披露半年报，公司上半年实现营业收入6.99亿元，同比增长29.55%，归母净利润亏损2740万元，上年同期亏损3963万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2025-08-26/doc-infnhekn1800203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0256","BK0262","601606","BK0046","BK0239","BK0028","300204"],"gpt_icon":0},{"id":"2562248929","title":"舒泰神最新公告：上半年净亏损2463.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562248929","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562248929?lang=zh_cn&edition=full","pubTime":"2025-08-25 18:19","pubTimestamp":1756117170,"startTime":"0","endTime":"0","summary":"舒泰神(300204.SZ)公告称，2025年上半年营业收入1.26亿元，同比下降31.14%。归属于上市公司股东的净亏损2463.56万元，上年同期净亏损342.3万元。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082500025782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0028","300204"],"gpt_icon":0},{"id":"2562296135","title":"舒泰神上涨6.99%，报56.18元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2562296135","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562296135?lang=zh_cn&edition=full","pubTime":"2025-08-25 09:41","pubTimestamp":1756086084,"startTime":"0","endTime":"0","summary":"8月25日，舒泰神盘中上涨6.99%，截至09:41，报56.18元/股，成交4.16亿元，换手率1.61%，总市值268.41亿元。截至3月31日，舒泰神股东户数2.45万，人均流通股1.93万股。2025年1月-3月，舒泰神实现营业收入6321.4万元，同比减少33.45%；归属净利润-233.5万元，同比增长38.05%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/25094152659389.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","BK0028","300204","BK0046"],"gpt_icon":0},{"id":"2561421400","title":"舒泰神：STSP-0902滴眼液获得I期临床研究总结报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2561421400","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561421400?lang=zh_cn&edition=full","pubTime":"2025-08-22 16:15","pubTimestamp":1755850548,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","BK0028","BK0046","300204"],"gpt_icon":0},{"id":"2560129127","title":"关于“舒泰神”交易风险提示公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2560129127","media":"银河证券服务","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560129127?lang=zh_cn&edition=full","pubTime":"2025-08-20 12:59","pubTimestamp":1755665940,"startTime":"0","endTime":"0","summary":"请您注意该证券二级市场交易风险，理性投资，审慎交易。请您及时通过交易所网站等指定信息披露媒体，查阅上市公司发布的公告信息，持续关注投资风险，审慎做出投资决策，谨慎、合规参与交易。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-08-20/doc-infmrakf1843924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","300204","BK0028","BK0046"],"gpt_icon":0},{"id":"2560155274","title":"异动快报：舒泰神（300204）8月19日10点45分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2560155274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560155274?lang=zh_cn&edition=full","pubTime":"2025-08-19 10:45","pubTimestamp":1755571522,"startTime":"0","endTime":"0","summary":"证券之星8月19日盘中消息，10点45分舒泰神触及涨停板。目前价格66.66，上涨20.0%。其所属行业化学制药目前上涨。该股为创新药，医药，新冠病毒防治概念热股，当日创新药概念上涨2.11%，医药概念上涨1.97%，新冠病毒防治概念上涨1.46%。8月18日的资金流向数据方面，主力资金净流入1.02亿元，占总成交额8.06%，游资资金净流出5471.59万元，占总成交额4.33%，散户资金净流出4715.11万元，占总成交额3.73%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081900013372.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300204","BK0239","BK0046"],"gpt_icon":0},{"id":"2559916961","title":"舒泰神最新公告：香塘集团计划减持不超过2%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2559916961","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559916961?lang=zh_cn&edition=full","pubTime":"2025-08-15 18:40","pubTimestamp":1755254414,"startTime":"0","endTime":"0","summary":"舒泰神(300204.SZ)公告称，公司持股5%以上股东香塘集团有限公司计划自本公告披露之日起15个交易日后的3个月内，以大宗交易和集中竞价方式分别减持公司股份不超过477.77万股，合计占公司总股本的2%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081500037650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","300204","BK0046","BK0239"],"gpt_icon":0},{"id":"2557551131","title":"舒泰神：BDB-001与AVACOPAN靶点相同但作用机制存在差异","url":"https://stock-news.laohu8.com/highlight/detail?id=2557551131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557551131?lang=zh_cn&edition=full","pubTime":"2025-08-08 11:33","pubTimestamp":1754623987,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神08月07日在投资者关系平台上答复投资者关心的问题。BDB001ANCA展开3期临床的同时是否审请附条件上市优先审评？BDB-001与AVACOPAN属于同类靶点药品，但BDB-001在分子结构、作用机制、临床特征等方面存在差异，BDB-001是C5a因子的大分子抗体类抑制剂，预期可阻断C5a/C5aR1及C5a/C5aR2通路活性。公司将继续推进BDB-001相关适应症的临床试验进展，有关研发项目进展敬请关注后续定期报告及项目进展公告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080800015403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204","BK0046","BK0028","BK0239"],"gpt_icon":0},{"id":"2556500278","title":"单抗概念盘中拉升，舒泰神涨9.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556500278","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556500278?lang=zh_cn&edition=full","pubTime":"2025-08-01 09:55","pubTimestamp":1754013350,"startTime":"0","endTime":"0","summary":"08月01日，单抗概念盘中拉升，截至09点55分，单抗概念整体指数上涨3.12%，报2832.270点。从个股上来看，该概念的成分股中，舒泰神涨9.85%，迈威生物-U、誉衡药业等3只股涨幅超过5%。从资金上来看，截止发稿，单抗概念概念主力净流入为8200.19万，其中誉衡药业受到资金热捧，主力净流入7994.70万；拉长时间线来看，该板块近20日主力资金净流入-19.03亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801095550a46ea148&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801095550a46ea148&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0046","BK0028","688062","300204","BK0239"],"gpt_icon":0},{"id":"2555647007","title":"舒泰神(300204.SZ)BDB-001注射液(ANCA相关性血管炎适应症)获I/II期临床研究总结报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2555647007","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555647007?lang=zh_cn&edition=full","pubTime":"2025-07-31 16:33","pubTimestamp":1753950818,"startTime":"0","endTime":"0","summary":"智通财经APP讯，舒泰神(300204.SZ)公告，公司取得关于BDB-001注射液(ANCA相关性血管炎适应症，AAV)的I/II期临床研究总结报告。本品已完成的I/II期临床试验中显示出较好的控制疾病缓解的效果，且安全耐受性良好。公司将积极推进Ⅲ期临床试验，进一步验证其治疗AAV患者的临床获益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324140.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"舒泰神(300204.SZ)BDB-001注射液(ANCA相关性血管炎适应症)获I/II期临床研究总结报告","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0046","BK0028","BK0239","300204"],"gpt_icon":0},{"id":"2555922002","title":"舒泰神：取得关于BDB-001注射液的I/II期临床研究总结报告","url":"https://stock-news.laohu8.com/highlight/detail?id=2555922002","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555922002?lang=zh_cn&edition=full","pubTime":"2025-07-31 16:08","pubTimestamp":1753949306,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1583","BK4588","AA","300204","161726","399441","BK4153","BK4585","BK0239","BK0046","03347","BK1576","BK0028","BK1141"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1759958173437,"stockEarnings":[{"period":"1week","weight":0.0055},{"period":"1month","weight":-0.3436},{"period":"3month","weight":-0.1425},{"period":"6month","weight":3.6432},{"period":"1year","weight":3.4373},{"period":"ytd","weight":3.7247}],"compareEarnings":[{"period":"1week","weight":0.0159},{"period":"1month","weight":0.0064},{"period":"3month","weight":0.1239},{"period":"6month","weight":0.1618},{"period":"1year","weight":0.1637},{"period":"ytd","weight":0.1584}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"舒泰神(北京)生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"31665人(较上一季度增加29.20%)","perCapita":"14327股","listingDate":"2011-04-15","address":"北京市大兴区北京经济技术开发区经海二路36号","registeredCapital":"47777万元","survey":"　　舒泰神(北京)生物制药股份有限公司的主营业务是生物药物的研发、生产和营销。公司的主要产品是创新生物药物苏肽生（注射用鼠神经生长因子）、特色品种舒泰清（复方聚乙二醇电解质散（IV））。","listedPrice":52.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"舒泰神(300204)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供舒泰神(300204)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"舒泰神,300204,舒泰神股票,舒泰神股票老虎,舒泰神股票老虎国际,舒泰神行情,舒泰神股票行情,舒泰神股价,舒泰神股市,舒泰神股票价格,舒泰神股票交易,舒泰神股票购买,舒泰神股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"舒泰神(300204)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供舒泰神(300204)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}